Emma is a licensing associate for the Life Sciences Team in the TTIC. She is responsible for evaluating early-stage technology disclosures, marketing, and accomplishing agreements. Emma started her career as an oncology researcher focused on elucidating cell signaling factors involved in brain metastasis, as well as developing a novel anti-cancer small molecule at the Wistar Institute. At the same time Emma worked in business development for a cancer research organization and for a university spinoff. Emma has an AS in healthcare management, a BS biology, and an MSc in biomedicine and business.